Lithium revisited

Canadian Journal of Psychiatry

Volumn 46, Issue 4, 2001, Pages 322-327

  McIntyre, R S ^a   Mancini, D A ^a   Parikh, S ^a   Kennedy, S H ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Augmentation; Bipolar disorder; Depression; Efficacy; Lithium; Renal toxicity; Suicide; Teratogenicity; Withdrawal

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CREATININE; LITHIUM; NEUROLEPTIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROATE SEMISODIUM;

CHEMOPROPHYLAXIS; DEPRESSION; DRUG BLOOD LEVEL; DRUG INDICATION; DRUG SAFETY; DRUG WITHDRAWAL; HUMAN; KIDNEY FAILURE; MANIA; MANIC DEPRESSIVE PSYCHOSIS; NEPHROGENIC DIABETES INSIPIDUS; NEPHROTOXICITY; NEUROPROTECTION; NEUROTROPISM; REVIEW; SUICIDE; TERATOGENICITY; WITHDRAWAL SYNDROME;

EID: 0034974809     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674370104600402     Document Type: Review

References (59)

1. Lithium: Evidence reconsidered
2. Lithium salts in the treatment of psychotic excitement
3. Prophylactic lithium: Double blind discontinuation in manic-depressive and recurrent-depressive disorders
4. Lithium as prophlyactic agent: Its effect against recurrent depression and manic-depressive psychosis
5. Treatment of mania, mixed states and rapid cycling
6. An update on the use of lithium carbonate in aggressive children and adolescents with conduct disorder
7. Update on pharmacological management of OCD: Agents and augmentation
8. Treatment of schizoaffective disorders
9. Evaluation of lithium treatment in alcoholism
10. Lithium in the treatment of other psychiatric and nonpsychiatric disorders
11. The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study
12. Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder
13. Valproate in the treatment of acute mania
14. Valproate oral loading in the treatment of acute mania
15. Chronic renal lesions following long-term treatment with lithium
16. Effects of the rate of discontinuing lithium maintenance treatment in bipolar disorders
17. Prophylactic lithium: Another therapeutic myth?
18. Lithium revisited: A re-examination of the placebo-controlled trials of lithium prophylaxis in manic-depressive disorder
19. Lithium in mania: Clinical trials and controlled studies
20. Efficacy of divalproex vs lithium and placebo in the treatment of mania
21. A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania
22. A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania
23. Comparison of lithium carbonate and chlorpromazme in the treatment of mania: Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group
24. Persistent tardive dyskinesia in bipolar patients
25. The lithium treatment of maniacal psychosis
26. Outcome in manic disorders
27. Bipolar I: A five-year prospective follow-up
28. Lithium prophylaxis of bipolar illness
29. Beyond lithium in the treatment of bipolar illness
30. Lithium prophylaxis in recurrent affective illness
31. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder
32. Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders
33. The use of lithium to augment antidepressant medication
34. Treatment of imipramine-resistant recurrent depression: IL An open clinical trial of lithium augmentation
35. Lithium-early development, toxicity, and renal function
36. Kidney damage in long-term lithium patients: A cross-sectional study of patients with 15 years or more on lithium
37. Lithium nephrotoxicity
38. Renal concentrating capacity in long term lithium treatment and after withdrawal of lithium
39. A reevaluation of risk of in utero exposure to lithium
40. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder
41. Episode frequency prior to lithium treatment in bipolar manic-depressive patients
42. Effects of the rate of discontinuing lithium maintenance treatment in bipolar disorders
43. Functional and structural rat kidney changes caused by peroral or parental lithium treatment
44. Effect of sustained-release lithium tablets on renal function
45. Lithium: Long-term effects on the kidney. II Structural changes
46. Lithium kinetics in single day dosing
47. Are the renal effects of lithium modified by frequency of administration
48. Is death from natural causes still excessive in psychiatric patients?
49. Causes of death in manic-depressives
50. The relationship of depression to cardiovascular disease
51. The effect of long-term lithium treatment on the mortality of patients with manic-depressive illness and schizoaffective illness
52. Effect of prophylactic treatment on suicide risk in patients with major affective disorders
53. Does lithium reduce the mortality of recurrent mood disorders?
54. Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis
55. The effects of lithium on impulsive aggressive behaviour in man
56. Lithium upregulates the cytoprotective protein bcl-2 in the cns in vivo: A role for neurotrophic and neuroprotective effects in manic depressive illness